Aquestive Therapeutics, Inc.
AQST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $72 | $24 | $27 | $28 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $7 | $8 | $5 | $12 |
| Inventory | $6 | $7 | $6 | $4 |
| Other Curr. Assets | $3 | $2 | $2 | $3 |
| Total Curr. Assets | $88 | $41 | $40 | $47 |
| Property Plant & Equip (Net) | $9 | $10 | $9 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $1 | $1 | $0 |
| Long-Term Investments | $3 | $4 | $0 | $6 |
| Tax Assets | $0 | $0 | $0 | -$6 |
| Other NC Assets | $1 | $1 | $6 | $7 |
| Total NC Assets | $13 | $16 | $17 | $15 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $101 | $57 | $57 | $62 |
| Liabilities | – | – | – | – |
| Payables | $10 | $9 | $10 | $8 |
| Short-Term Debt | $1 | $0 | $19 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $2 | $2 | $1 |
| Other Curr. Liab. | $7 | $7 | $9 | $10 |
| Total Curr. Liab. | $19 | $18 | $40 | $22 |
| LT Debt | $37 | $33 | $39 | $53 |
| Deferred Rev, NC | $20 | $32 | $31 | $7 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $59 |
| Other NC Liab. | $85 | $80 | $66 | $2 |
| Total NC Liab. | $143 | $146 | $136 | $122 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $6 | $5 | $3 |
| Total Liabilities | $162 | $164 | $176 | $144 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$363 | -$319 | -$311 | -$257 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $303 | $213 | $193 | $175 |
| Total Equity | -$60 | -$106 | -$119 | -$82 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $101 | $57 | $57 | $62 |
| Net Debt | -$34 | $9 | $30 | $28 |